Ceftriaxone & Tazobactam Injection 562.5 mg Supplier for Abu Dhabi, United Arab Emirates
High-Performance Sterile Antibiotic Injection from India
Ernest Oncology presents Ceftriaxone & Tazobactam Injection 562.5 mg, an advanced sterile injectable formulation containing Ceftriaxone 500 mg and Tazobactam 62.5 mg. Produced in WHO-GMP certified pharmaceutical facilities in India, the medicine is manufactured using modern sterile technology, ensuring exceptional pharmaceutical quality, purity, and batch consistency.
The formulation is intended for intramuscular (IM) and intravenous (IV) administration under the supervision of qualified healthcare professionals.
Abu Dhabi Pharmaceutical Market Information
Abu Dhabi continues to strengthen its position as a regional healthcare leader with internationally accredited hospitals, advanced medical facilities, and rapidly expanding healthcare infrastructure. Healthcare providers increasingly depend on pharmaceutical products manufactured under globally recognized quality systems that emphasize patient safety and treatment reliability.
India has become a preferred pharmaceutical manufacturing destination because of its strong regulatory compliance, advanced production capabilities, and internationally accepted quality standards.
Why Choose Indian Pharmaceutical Exports
India has earned worldwide recognition as one of the largest pharmaceutical manufacturing hubs.
Advantages of Indian Pharmaceutical Products
- WHO-GMP certified production facilities
- Globally recognized manufacturing standards
- Advanced sterile pharmaceutical technology
- High-quality active pharmaceutical ingredients
- Reliable batch-to-batch consistency
- Comprehensive quality assurance systems
- Export-ready pharmaceutical packaging
- Continuous manufacturing innovation
- Strong international healthcare reputation
- Commitment to pharmaceutical excellence
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 562.5 mg |
| Composition | Ceftriaxone 500 mg + Tazobactam 62.5 mg |
| Dosage Form | Sterile Powder for Injection |
| Route of Administration | IM / IV |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Ceftriaxone and Tazobactam combination therapy
- Broad-spectrum antibacterial formulation
- Sterile powder for injection
- WHO-GMP certified manufacturing
- Pharmaceutical-grade formulation
- Excellent product stability
- Consistent manufacturing quality
- Export-quality packaging
- Advanced sterile production process
- International quality compliance
Product Description
Ceftriaxone & Tazobactam Injection 562.5 mg combines the antibacterial properties of Ceftriaxone, a third-generation cephalosporin antibiotic, with Tazobactam, a beta-lactamase inhibitor that enhances antibacterial activity by protecting Ceftriaxone from bacterial enzyme degradation.
The medicine is formulated as a sterile injectable preparation for administration by qualified healthcare professionals through intramuscular (IM) or intravenous (IV) routes.
Side Effects
Some patients may experience temporary side effects during treatment.
Possible side effects include:
- Pain or redness at the injection site
- Nausea
- Vomiting
- Diarrhea
- Headache
- Fever
- Skin rash
- Dizziness
- Allergic reactions
- Temporary elevation of liver enzyme levels
Seek medical advice if any symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- Use only under qualified medical supervision.
- Inform your healthcare provider about any known allergies before treatment.
- Complete the prescribed treatment course.
- Follow all medical instructions carefully.
- Do not use expired medicine.
- Keep out of reach of children.
Storage Information
- Store below 25°C
- Protect from moisture
- Keep away from direct sunlight
- Store in the original packaging
- Do not freeze
- Use before the expiry date
Quality Assurance
Every batch manufactured for Ernest Oncology undergoes comprehensive quality verification to ensure compliance with international pharmaceutical standards.
Our Quality Commitment
- WHO-GMP certified manufacturing facilities
- Sterile production environment
- Batch-wise laboratory testing
- Product traceability systems
- Export-quality packaging
- Controlled storage conditions
- Documentation verification
- Continuous quality improvement
Documentation
The following documents are generally available with export shipments:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP)* (where applicable)
- Batch Manufacturing Record* (where available)
- Airway Bill / Bill of Lading
Mechanism of Action
The combination delivers enhanced antibacterial activity through two complementary actions.
- Ceftriaxone interferes with bacterial cell wall synthesis, resulting in bacterial destruction.
- Tazobactam blocks beta-lactamase enzymes produced by resistant bacteria, helping preserve Ceftriaxone's antibacterial effectiveness.
Together, they provide broader antibacterial coverage against susceptible bacterial pathogens.
Recommended Dosage
The appropriate dosage should always be determined by a qualified healthcare professional.
Dosage depends on:
- Type of bacterial infection
- Severity of the condition
- Patient age
- Body weight
- Kidney function
- Individual clinical assessment
Partner with Ernest Oncology
Ernest Oncology is driven by a commitment to pharmaceutical innovation, uncompromising quality, and responsible healthcare manufacturing. Every product reflects our dedication to delivering reliable medicines manufactured in India while supporting healthier communities through internationally recognized pharmaceutical standards.
Frequently Asked Questions (FAQs)
1. What is Ceftriaxone & Tazobactam Injection 562.5 mg?
It is a sterile injectable antibiotic containing Ceftriaxone 500 mg and Tazobactam 62.5 mg, prescribed for susceptible bacterial infections.
2. How is this medicine administered?
It is administered through intramuscular (IM) or intravenous (IV) injection under the supervision of qualified healthcare professionals.
3. What is the role of Tazobactam?
Tazobactam inhibits beta-lactamase enzymes, helping maintain the antibacterial activity of Ceftriaxone.
4. How should Ceftriaxone & Tazobactam Injection 562.5 mg be stored?
Store below 25°C, protected from moisture and direct sunlight, in its original packaging.
5. Is this medicine available without a prescription?
No. It is a prescription-only medicine and should only be used under the guidance of a qualified healthcare professional.
📞 Contact Ernest Oncology — Global Healthcare Medicine Supplier
A Specialized Healthcare Brand of Ernest Pharmaceutical Pvt. Ltd.
🌐 Visit Our Healthcare Platforms
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
- www.ernestvision.com
- www.ernestimpex.com
📧 Email Us
Email: exports@ernestpharmaceuticals.com
🌍 Our Services
- Inspiring Better Healthcare
- Trusted Pharmaceutical Innovation
- Quality Medicines Manufactured in India
- Supporting Health Across Borders
+91 93599 02383
Medical Disclaimer
- Ceftriaxone Sodium & Tazobactam Sodium Injection
- Ceftriaxone & Tazobactam Sterile Powder for Injection
- Ceftriaxone & Tazobactam IM/IV Injection
- Ceftriaxone & Tazobactam Dry Powder Injection
- Ceftriaxone & Tazobactam Broad-Spectrum Antibiotic Injection
Written By
Chaitali H.
B. Pharma
